Interleukin-18 promoter -607 C/A and -137 G/C polymorphisms and susceptibility to type 1 diabetes

A meta-analysis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The aim of this study was to determine whether the functional interleukin-18 (IL-18) promoter -607 C/A (rs1946518) and -137 G/C (rs187238) polymorphisms are associated with susceptibility to type 1 diabetes (TID). Methods: A meta-analysis was conducted to assess the associations between the IL-18-607 C/A and -137 G/C polymorphisms and T1D in overall and by ethnic group. Results: A total of 6075 cases and 5744 controls from ten studies were considered in this meta-analysis. In all study subjects, the meta-analysis showed no association between T1D and the IL-18-607 C allele (OR = 1.083, 95% CI = 0.930-1.260, p = 0.307). However, stratification by ethnicity indicated an association between the IL-18-607 C allele and T1D in Asians (OR = 1.506, 95% CI = 1.172-1.936, p = 0.001), but not in Europeans (OR = 0.988, 95% CI = 0.808-1.209, p = 0.907). Analysis using recessive and dominant models and homozygote contrast showed the same -607 C allele pattern in Asians and Europeans. Meta-analysis of the IL-18-137 G/C polymorphism showed no association between T1D and the IL-18-137 G allele in all study subjects (OR = 1.066, 95% CI = 0.926-1.2289, p = 0.375). Stratification by ethnicity indicated no association between the IL-18-137 G allele and T1D in Europeans and Asians (OR = 1.021, 95% CI = 0.961-1.085, p = 0.504; OR = 0.851, 95% CI = 0.5821-1.245, p = 0.406). Conclusions: Our meta-analysis demonstrates that the IL-18-607 C/A polymorphism may be associated with susceptibility to T1D in Asians, but not in Europeans.

Original languageEnglish
Pages (from-to)537-545
Number of pages9
JournalHuman Immunology
Volume76
Issue number8
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Interleukin-18
Type 1 Diabetes Mellitus
Meta-Analysis
Alleles
Homozygote
Ethnic Groups

Keywords

  • Interleukin-18
  • Meta-analysis
  • Polymorphism
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Interleukin-18 promoter -607 C/A and -137 G/C polymorphisms and susceptibility to type 1 diabetes : A meta-analysis. / Lee, Young Ho; Kim, Jae Hoon; Song, Gwan Gyu.

In: Human Immunology, Vol. 76, No. 8, 01.01.2015, p. 537-545.

Research output: Contribution to journalArticle

@article{0d9c4138044e4634b139e930c58e4340,
title = "Interleukin-18 promoter -607 C/A and -137 G/C polymorphisms and susceptibility to type 1 diabetes: A meta-analysis",
abstract = "Objective: The aim of this study was to determine whether the functional interleukin-18 (IL-18) promoter -607 C/A (rs1946518) and -137 G/C (rs187238) polymorphisms are associated with susceptibility to type 1 diabetes (TID). Methods: A meta-analysis was conducted to assess the associations between the IL-18-607 C/A and -137 G/C polymorphisms and T1D in overall and by ethnic group. Results: A total of 6075 cases and 5744 controls from ten studies were considered in this meta-analysis. In all study subjects, the meta-analysis showed no association between T1D and the IL-18-607 C allele (OR = 1.083, 95{\%} CI = 0.930-1.260, p = 0.307). However, stratification by ethnicity indicated an association between the IL-18-607 C allele and T1D in Asians (OR = 1.506, 95{\%} CI = 1.172-1.936, p = 0.001), but not in Europeans (OR = 0.988, 95{\%} CI = 0.808-1.209, p = 0.907). Analysis using recessive and dominant models and homozygote contrast showed the same -607 C allele pattern in Asians and Europeans. Meta-analysis of the IL-18-137 G/C polymorphism showed no association between T1D and the IL-18-137 G allele in all study subjects (OR = 1.066, 95{\%} CI = 0.926-1.2289, p = 0.375). Stratification by ethnicity indicated no association between the IL-18-137 G allele and T1D in Europeans and Asians (OR = 1.021, 95{\%} CI = 0.961-1.085, p = 0.504; OR = 0.851, 95{\%} CI = 0.5821-1.245, p = 0.406). Conclusions: Our meta-analysis demonstrates that the IL-18-607 C/A polymorphism may be associated with susceptibility to T1D in Asians, but not in Europeans.",
keywords = "Interleukin-18, Meta-analysis, Polymorphism, Type 1 diabetes",
author = "Lee, {Young Ho} and Kim, {Jae Hoon} and Song, {Gwan Gyu}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.humimm.2015.06.012",
language = "English",
volume = "76",
pages = "537--545",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Interleukin-18 promoter -607 C/A and -137 G/C polymorphisms and susceptibility to type 1 diabetes

T2 - A meta-analysis

AU - Lee, Young Ho

AU - Kim, Jae Hoon

AU - Song, Gwan Gyu

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: The aim of this study was to determine whether the functional interleukin-18 (IL-18) promoter -607 C/A (rs1946518) and -137 G/C (rs187238) polymorphisms are associated with susceptibility to type 1 diabetes (TID). Methods: A meta-analysis was conducted to assess the associations between the IL-18-607 C/A and -137 G/C polymorphisms and T1D in overall and by ethnic group. Results: A total of 6075 cases and 5744 controls from ten studies were considered in this meta-analysis. In all study subjects, the meta-analysis showed no association between T1D and the IL-18-607 C allele (OR = 1.083, 95% CI = 0.930-1.260, p = 0.307). However, stratification by ethnicity indicated an association between the IL-18-607 C allele and T1D in Asians (OR = 1.506, 95% CI = 1.172-1.936, p = 0.001), but not in Europeans (OR = 0.988, 95% CI = 0.808-1.209, p = 0.907). Analysis using recessive and dominant models and homozygote contrast showed the same -607 C allele pattern in Asians and Europeans. Meta-analysis of the IL-18-137 G/C polymorphism showed no association between T1D and the IL-18-137 G allele in all study subjects (OR = 1.066, 95% CI = 0.926-1.2289, p = 0.375). Stratification by ethnicity indicated no association between the IL-18-137 G allele and T1D in Europeans and Asians (OR = 1.021, 95% CI = 0.961-1.085, p = 0.504; OR = 0.851, 95% CI = 0.5821-1.245, p = 0.406). Conclusions: Our meta-analysis demonstrates that the IL-18-607 C/A polymorphism may be associated with susceptibility to T1D in Asians, but not in Europeans.

AB - Objective: The aim of this study was to determine whether the functional interleukin-18 (IL-18) promoter -607 C/A (rs1946518) and -137 G/C (rs187238) polymorphisms are associated with susceptibility to type 1 diabetes (TID). Methods: A meta-analysis was conducted to assess the associations between the IL-18-607 C/A and -137 G/C polymorphisms and T1D in overall and by ethnic group. Results: A total of 6075 cases and 5744 controls from ten studies were considered in this meta-analysis. In all study subjects, the meta-analysis showed no association between T1D and the IL-18-607 C allele (OR = 1.083, 95% CI = 0.930-1.260, p = 0.307). However, stratification by ethnicity indicated an association between the IL-18-607 C allele and T1D in Asians (OR = 1.506, 95% CI = 1.172-1.936, p = 0.001), but not in Europeans (OR = 0.988, 95% CI = 0.808-1.209, p = 0.907). Analysis using recessive and dominant models and homozygote contrast showed the same -607 C allele pattern in Asians and Europeans. Meta-analysis of the IL-18-137 G/C polymorphism showed no association between T1D and the IL-18-137 G allele in all study subjects (OR = 1.066, 95% CI = 0.926-1.2289, p = 0.375). Stratification by ethnicity indicated no association between the IL-18-137 G allele and T1D in Europeans and Asians (OR = 1.021, 95% CI = 0.961-1.085, p = 0.504; OR = 0.851, 95% CI = 0.5821-1.245, p = 0.406). Conclusions: Our meta-analysis demonstrates that the IL-18-607 C/A polymorphism may be associated with susceptibility to T1D in Asians, but not in Europeans.

KW - Interleukin-18

KW - Meta-analysis

KW - Polymorphism

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84953368688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953368688&partnerID=8YFLogxK

U2 - 10.1016/j.humimm.2015.06.012

DO - 10.1016/j.humimm.2015.06.012

M3 - Article

VL - 76

SP - 537

EP - 545

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 8

ER -